Quarterly report · Q3
7730.TEDINET S100OQC2
Period2021-09-01 → 2022-05-31
Filed2022-07-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.8bn | 2021-09-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥17.2bn | 2020-09-01 → 2021-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2020-09-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥4.5bn | 2021-09-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥4.3bn | 2020-09-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥5.5bn | 2021-09-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2020-09-01 → 2021-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.6bn | 2020-09-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.5bn | 2021-09-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.9bn | 2020-09-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.8bn | 2021-09-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.3bn | 2020-09-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2020-09-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.8bn | 2021-09-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2020-09-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥46.4bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥42.7bn | at 2021-08-31 | Cons. | Assets |
| Total assets | ¥41.7bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.7bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥3.5bn | at 2021-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥42.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥39.2bn | at 2021-08-31 | Cons. | Net assets |
| Net assets / equity | ¥38.4bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.3bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.3bn | at 2021-08-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥38.51 | 2021-09-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.81 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.6 | 2020-09-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.36 | 2020-09-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.89 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 92.0% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.2% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-09-01 → 2022-05-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-09-01 → 2022-05-31 | −¥2m |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | segment profit | 2021-09-01 → 2022-05-31 | ¥1.9bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2021-09-01 → 2022-05-31 | ¥2m |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | segment profit | 2021-09-01 → 2022-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | revenue | 2021-09-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | revenue external | 2021-09-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | segment profit | 2021-09-01 → 2022-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-05-31 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-05-31 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-09-01 → 2022-05-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-05-31 | ¥4.5bn |
| Reconciling Itemsreconciling | revenue | 2020-09-01 → 2021-05-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-09-01 → 2021-05-31 | −¥1m |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | revenue | 2020-09-01 → 2021-05-31 | ¥5.6bn |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | revenue external | 2020-09-01 → 2021-05-31 | ¥5.6bn |
| jpcrp040300-q3r_E02340-000Dentalreportable segment | segment profit | 2020-09-01 → 2021-05-31 | ¥1.8bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue | 2020-09-01 → 2021-05-31 | ¥3.7bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue external | 2020-09-01 → 2021-05-31 | ¥3.7bn |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2020-09-01 → 2021-05-31 | ¥1m |
| jpcrp040300-q3r_E02340-000Eyeless Needlereportable segment | segment profit | 2020-09-01 → 2021-05-31 | ¥1.2bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | revenue | 2020-09-01 → 2021-05-31 | ¥3.6bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | revenue external | 2020-09-01 → 2021-05-31 | ¥3.6bn |
| jpcrp040300-q3r_E02340-000Surgicalreportable segment | segment profit | 2020-09-01 → 2021-05-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-09-01 → 2021-05-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-09-01 → 2021-05-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-09-01 → 2021-05-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-09-01 → 2021-05-31 | ¥4.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 386
| Item | Context | Value | Unit |
|---|---|---|---|
| Valuation and translation adjustments | Prior1YearInstant | 552000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2657000000 | JPY |
| Net assets | Prior1YearInstant | 39202000000 | JPY |
| Net assets | CurrentQuarterInstant | 42736000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 42693000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 46437000000 | JPY |
| Net sales | Prior1YTDDuration | 12935000000 | JPY |
| Net sales | CurrentYTDDuration | 14830000000 | JPY |
| Cost of sales | Prior1YTDDuration | 4575000000 | JPY |
| Cost of sales | CurrentYTDDuration | 5793000000 | JPY |
| Gross profit | Prior1YTDDuration | 8360000000 | JPY |
| Gross profit | CurrentYTDDuration | 9036000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 4092000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 4493000000 | JPY |
| Operating income | Prior1YTDDuration | 4268000000 | JPY |
| Operating income | CurrentYTDDuration | 4543000000 | JPY |
| Interest income noi | Prior1YTDDuration | 52000000 | JPY |
| Interest income noi | CurrentYTDDuration | 82000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1000000 | JPY |
| Dividends income noi | CurrentYTDDuration | - | JPY |
| Gain on investments in partnership noi | Prior1YTDDuration | 4000000 | JPY |
| Gain on investments in partnership noi | CurrentYTDDuration | 9000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 384000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 886000000 | JPY |
| Other noi | Prior1YTDDuration | 11000000 | JPY |
| Other noi | CurrentYTDDuration | 40000000 | JPY |
| Non operating income | Prior1YTDDuration | 455000000 | JPY |
| Non operating income | CurrentYTDDuration | 1019000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 1000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 1000000 | JPY |
| Commission for syndicate loan noe | Prior1YTDDuration | 2000000 | JPY |
| Commission for syndicate loan noe | CurrentYTDDuration | 2000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 13000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | - | JPY |
| Compensation for leave of absence at home noe | Prior1YTDDuration | 58000000 | JPY |
| Compensation for leave of absence at home noe | CurrentYTDDuration | - | JPY |
| Foreign value added tax etc noe | Prior1YTDDuration | 22000000 | JPY |
| Foreign value added tax etc noe | CurrentYTDDuration | 6000000 | JPY |
| Unoperated land related costs noe | Prior1YTDDuration | - | JPY |
| Unoperated land related costs noe | CurrentYTDDuration | 26000000 | JPY |
| Other noe | Prior1YTDDuration | 4000000 | JPY |
| Other noe | CurrentYTDDuration | 4000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 102000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 41000000 | JPY |
| Ordinary income | Prior1YTDDuration | 4621000000 | JPY |
| Ordinary income | CurrentYTDDuration | 5521000000 | JPY |
| Surrender value of insurance ei | Prior1YTDDuration | 2000000 | JPY |
| Surrender value of insurance ei | CurrentYTDDuration | 5000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 0 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 4000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |